Efforts to identify a neuroprotective agent are ongoing globally. The task for researchers is to not only develop a neuroprotective compound with efficacy for human use, but also to determine new ...

Background: The glaucomas are generally asymptomatic diseases until they are very advanced. They affect 2% of the population over 40 years of age and therefore represent a significant public ...